Evidence map›Paper›PMID 40237586›Full record

ArticleJournal of radiation research2025

A Japanese national survey on IMRT/SBRT in 2023 by the JASTRO High-Precision External Beam Radiotherapy Group.

Masahide Saito, Shuichi Ozawa, Takafumi Komiyama, Masaki Kokubo, Yoshiyuki Shioyama, Yukinori Matsuo, Takashi Mizowaki, Tomoki Kimura, Hideyuki Harada, Hiroshi Igaki and 8 more

Abstract read
In one paragraph

Article in Journal of radiation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Geographic access to radiotherapy facilities in Japan.Journal of radiation research · 2026
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Masahide SaitoDepartment of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, Yamanashi 409-3898, Japan.
Shuichi OzawaDivision of Medical Physics, Hiroshima High-Precision Radiotherapy Cancer Center, 3-2-2, Futabanosato, Higashiku, Hiroshima, Hiroshima 732-0057, Japan.
Takafumi KomiyamaDepartment of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, Yamanashi 409-3898, Japan.
Masaki KokuboDepartment of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima-Minamimachi, Chuo, Kobe, Hyogo 650-0047, Japan.
Yoshiyuki ShioyamaDivision of Radiation Oncology, Ion Beam Therapy Center, SAGA-HIMAT Foundation, 3049, Harakoga-machi, Tosu, Saga 841-0071, Japan.
Yukinori MatsuoDepartment of Radiation Oncology, Kindai University Faculty of Medicine, 377-2 Ono-higashi, Osaka-sayama, Osaka 589-8511, Japan.
Takashi MizowakiDepartment of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, 54 Shogoinkawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Tomoki KimuraDepartment of Radiation Oncology Kochi Medical School, Kochi University, Kohasu, Okou Town, Nankoku City, Kochi 783-8505, Japan.
Hideyuki HaradaDivision of Radiation Therapy, Shizuoka Cancer Center Hospital, 1007 shimonagakubo, nagaizumi-cho, sunto-gun, Shizuoka 411-8777, Japan.
Hiroshi IgakiDepartment of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Naoki TohyamaDepartment of Radiological Sciences, Komazawa University, 1-23-1 Komazawa, Setagaya-Ku, Tokyo 154-8525, Japan.
Masahiko KurookaDepartment of Radiation Therapy, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan.
Mitsuhiro NakamuraDepartment of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, 53 Shogoinkawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
Yu KumazakiDepartment of Radiation Oncology, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama 350-1298, Japan.
Hidekazu SuzukiDepartment of Radiological Technology, Faculty of Medical Technology, Teikyo University, 2-11-1 Kaga, Itabashi-Ku, Tokyo 173-8605, Japan.
Hikaru NemotoDepartment of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, Yamanashi 409-3898, Japan.
Nagata YasushiDepartment of Radiation Oncology, Chugoku Rosai Hospital, Hirotagaya 1-5-1, Kure, Hiroshima 737-0193, Japan.
Hiroshi OnishiDepartment of Radiology, University of Yamanashi, 1110 Shimokato, Chuo-city, Yamanashi, Yamanashi 409-3898, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the utilization and implementation of stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT) in Japan up to 2023. The survey was conducted by the Japanese Society for Radiation Oncology High-Precision External Beam Radiotherapy Group Subcommittee from December 2023 to February 2024. The study targeted patients treated with IMRT or SBRT between January 2021 and December 2022. A comprehensive web-based questionnaire was distributed to 880 facilities, with separate sections for radiation oncologists and medical physicists/radiotherapy technologists. A total of 360 facilities responded (response rate: 40.9%) for the section of radiation oncologists, and 405 facilities responded (response rate: 46.0%) for medical physicists/radiotherapy technologists, providing data on the implementation status, techniques, workload and challenges associated with IMRT and SBRT. Based on the responses in the section of radiation oncologists, IMRT was used in 68.6% of responding institutes, and SBRT in 87.8%. VMAT emerged as the most common IMRT technique (78.3%). The survey highlighted a high demand for medical physicists to perform IMRT (86.9%). Based on the responses in the section of medical physicists/radiotherapy technologists, 84.6% of the facilities that have not performed IMRT reported that the main reason was a lack of radiation oncologists. Furthermore, the survey also noted significant variations in prescribed doses and margin sizes across facilities, indicating the need for further standardization. High-precision radiation techniques such as IMRT and SBRT are getting popular, however, the facility requirements which mandate the presence of at least two radiation oncologists prevents IMRT from becoming more widespread in Japan.

Indexed as

RadiosurgeryRadiotherapy, Intensity-ModulatedEast Asian PeopleHumansJapanSurveys and QuestionnairesIGRTIMRTrespiratory motion managementSBRT

Identifiers

PMID40237586
PMCPMC12100480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.